Is Lilly Stock a Portfolio Must Have Ahead of its Q3 Earnings? - MSN

Eli Lilly and Company LLY will report its third-quarter 2024 earnings on Oct. 30, before market open. The Zacks Consensus Estimate for sales and earnings is pegged at $12.03 billion and $1.53 per ...

CouponFollow Extension

$12.03
OFF

Is Lilly Stock A Portfolio Must Have Ahead Of Its Q3 Earnings? - MSN

3 weeks from now

Eli Lilly and Company LLY will report its third-quarter 2024 earnings on Oct. 30, before market open. The Zacks Consensus Estimate for sales and earnings is pegged at $12.03 billion and $1.53 per ...

msn.com

$1.53
OFF

Lilly (LLY) Q3 Earnings On The Horizon: Analysts' Insights On Key ...

3 weeks from now

Oct 25, 2024 · In its upcoming report, Eli Lilly (LLY Quick Quote LLY - Free Report) is predicted by Wall Street analysts to post quarterly earnings of $1.53 per share, reflecting an increase of …

zacks.com

37%
OFF

Eli Lilly (LLY) Lags Q3 Earnings And Revenue Estimates - Yahoo …

3 weeks from now

Oct 30, 2024 · Lilly (LLY) delivered earnings and revenue surprises of -22.37% and 4.92%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies …

yahoo.com

20%
OFF

Eli Lilly Just Hit A Milestone That Disappointed. Here's Why You …

3 weeks from now

Nov 8, 2024 · During Q3, Eli Lilly brought in $11.4 billion in sales, up 20% from a year prior, and non-GAAP (adjusted) EPS of $1.18, which was $0.29 less than what the average of Wall …

fool.com

11%
OFF

Eli Lilly Just Hit A Milestone That Disappointed. Here's Why You …

3 weeks from now

Nov 8, 2024 · Even a juggernaut like Eli Lilly (NYSE: LLY) can miss the mark sometimes. When it reported its third-quarter earnings on Oct. 30, its share price plunged to the tune of 11% before …

yahoo.com

$450.00
OFF

Going Into Earnings, Is Eli Lilly Stock A Buy, A Sell, Or ... - Morningstar

3 weeks from now

Jan 29, 2024 · Here’s Morningstar’s take on what to look for in Eli Lilly’s earnings and our outlook for its stock. Key Morningstar Metrics for Eli Lilly Stock Fair Value Estimate : $450.00

morningstar.com

1430%
OFF

Lilly (LLY) Q3 Earnings On The Horizon: Analysts' Insights On Key ...

3 weeks from now

Oct 25, 2024 · In its upcoming report, Eli Lilly (LLY) is predicted by Wall Street analysts to post quarterly earnings of $1.53 per share, reflecting an increase of 1430% compared to the same …

nasdaq.com

25%
OFF

After Earnings, Is Eli Lilly Stock A Buy, A Sell, Or Fairly Valued?

3 weeks from now

Aug 15, 2024 · Lilly’s diversified product portfolio means the company’s top drugs represent only a moderate amount of total sales, with the largest drug, Trulicity, representing almost 25% of …

morningstar.com

37%
OFF

Eli Lilly (LLY) Lags Q3 Earnings And Revenue Estimates

3 weeks from now

Oct 30, 2024 · Lilly (LLY) delivered earnings and revenue surprises of -22.37% and 4.92%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies …

zacks.com

$13.02
OFF

Eli Lilly And Company (LLY) Earnings Date And Reports 2025

3 weeks from now

1 day ago · Eli Lilly and Company updated its FY24 earnings guidance on Wednesday, October, 30th. The company provided earnings per share (EPS) guidance of $13.02-13.52 for the …

marketbeat.com

5%
OFF

Eli Lilly And Company (LLY) Is Attracting Investor Attention

3 weeks from now

17 hours ago · Lilly is expected to post earnings of $5.49 per share for the current quarter, representing a year-over-year change of +120.5%. Over the last 30 days, the Zacks …

nasdaq.com

35%
OFF

Is Now A Good Time To Buy The Dip In Eli Lilly Stock?

3 weeks from now

Dec 21, 2024 · Since pharmaceutical giant Eli Lilly (LLY 1.35%) reported earnings for the third quarter on Oct. 30, shares have been punished by investors. As of this writing, Lilly's stock …

fool.com

22%
OFF

MillerKnoll (MLKN) Earnings Date And Reports 2025 - MarketBeat

3 weeks from now

4 days ago · Roblox Stock Soars 22% After Q3 Earnings – A Turning Point Ahead? Apple Earnings - When Really Good Just Isn’t Good Enough ; Last time you’ll see this priced at …

marketbeat.com

FAQs about Is Lilly Stock a Portfolio Must Have Ahead of its Q3 Earnings? - MSN Coupon?

What happened to Eli Lilly's stock after Q3 earnings?

Since pharmaceutical giant Eli Lilly (LLY 1.35%) reported earnings for the third quarter on Oct. 30, shares have been punished by investors. As of this writing, Lilly's stock price has plunged as much as 14% since Q3 earnings, and it's currently trading 6% lower than it was prior to the report. ...

When will Eli Lilly's third-quarter earnings report be released?

Eli Lilly LLY is set to release its third-quarter earnings report on Oct. 30. Here’s Morningstar’s take on what to look for in Eli Lilly’s earnings and stock. The biggest question is how quickly sales of Mounjaro and Zepbound (both using the same tirzepatide molecule) are growing in diabetes and obesity. ...

How much does Eli Lilly (LLY) earn per share?

Eli Lilly (LLY) came out with quarterly earnings of $1.18 per share, missing the Zacks Consensus Estimate of $1.52 per share. This compares to earnings of $0.10 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of -22.37%. ...

How will Eli Lilly & company's earnings perform next year?

Quarterly revenue rose 20.4% year-over-year to $11.44 billion, below analyst estimates of $12.09 billion. With a trailing EPS of $9.25 and a P/E Ratio of 81.84, Eli Lilly and Company's earnings are expected to grow 79.29% next year, from $13.18 to $23.63 per share. Want to stay updated on the latest earnings announcements and upcoming reports? ...

Did the market overreact to Lilly's Q3 earnings miss?

The market overreacted to Lilly's Q3 earnings miss and full-year guidance cut. High-flying aircraft experience turbulence from time to time. It's the same story with stocks. We saw that happen with Eli Lilly (LLY -2.02%) this week. Lilly announced its third-quarter results on Wednesday. Investors didn't like what they heard. ...

Why did Lilly's shares sank after its Q3 update?

It's not surprising that Lilly's shares sank after its Q3 update. The drugmaker badly missed Wall Street's revenue and earnings estimates. Lilly cut its full-year earnings guidance. However, a little digging into the rest of the story convinced me that the initial concerns about Lilly's Q3 update are overblown. ...